Acetylation of p53 Inhibits Its Ubiquitination by Mdm2
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In response to DNA damage, the activity of the p53 tumor suppressor is modulated by protein stabilization and post-translational modifications including acetylation. Interestingly, both acetylation and ubiquitination can modify the same lysine residues at the C terminus of p53, implicating a role of acetylation in the regulation of p53 stability. However, the direct effect of acetylation on Mdm2-mediated ubiquitination of p53 is still lacking because of technical difficulties. Here, we have developed a method to obtain pure acetylated p53 proteins from cells, and by using an in vitro purified system, we provide the direct evidence that acetylation of the C-terminal domain is sufficient to abrogate its ubiquitination by Mdm2. Importantly, even in the absence of DNA damage, acetylation of the p53 protein is capable of reducing the ubiquitination levels and extending its half-life in vivo. Moreover, we also show that acetylation of p53 can affect its ubiquitination through other mechanisms in addition to the site competition. This study has significant implications regarding a general mechanism by which protein acetylation modulates ubiquitination-dependent proteasome proteolysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon DNA damage, p53 becomes acetylated at multiple residues within its C-terminal domain to stabilize the protein via directly blocking ubiquitination at acetylated sites as well as hindering the interaction between p53 and MDM2 to discourage ubiquitination at unacetylated sites [47,48].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [48]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Self-citationThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Research works printed but not linked: 1
- Appella, 2000, Pathol. Biol. (Paris), 48, 227
Cited by
Items 201–300 of 520
Protein lysine acetylation in cellular function and its role in cancer manifestation
Arif, M., Senapati, P., Shandilya, J., & Kundu, T. K. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.10.002 · Cited by 61
Lin, T., Mak, N. K., & Yang, M. S. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.017 · Cited by 61
Seo, S., Jin, H., Woo, S., Kim, Y., An, S., Lee, J. H., Hong, S., Lee, K.-H., Choe, T., & Park, I. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318220caff · Cited by 60
p53 ubiquitination by Mdm2: A never ending tail?
Coutts, A. S., Adams, C., & Thangue, N. B. L. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.008 · Cited by 73
Muscolini, M., Cianfrocca, R., Sajeva, A., Mozzetti, S., Ferrandina, G., Costanzo, A., & Tuosto, L. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0299 · Cited by 56
HDAC Inhibitors and Cancer Therapy
Atadja, P. W. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_9 · Cited by 63
Zhang, J., Kan, S., Huang, B., Hao, Z., Mak, T. W., & Zhong, Q. (2011) · Genes & Development · doi:10.1101/gad.170605.111 · Cited by 58
Deciphering the PTM codes of the tumor suppressor p53
Wen, J., & Wang, D. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab047 · Cited by 59
Reversible acetylation of non histone proteins: role in cellular function and disease.
Batta, K., Das, C., Gadad, S. S., Shandilya, J., & Kundu, T. K. (2007) · PubMed · Cited by 59
Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination
Li, K., Wang, R., Lozada, E., Fan, W., Orren, D. K., & Luo, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010341 · Cited by 54
Self-citationNuclear proteins acting on mitochondria
Lindenboim, L., Borner, C., & Stein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.016 · Cited by 56
O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells
Lee, S. J., & Kwon, O. (2020) · Cancers · doi:10.3390/cancers12113154 · Cited by 58
Bartel, F., Harris, L. C., Würl, P., & Taubert, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.29.2.1 · Cited by 52
The Function and related Diseases of Protein Crotonylation
Wang, S., Mu, G., Qiu, B., Wang, M., Yu, Z., Wang, W., Wang, J., & Yang, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58872 · Cited by 55
Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription
Wang, X. D., Morgan, S. C., & Loeken, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029379 · Cited by 54
The transcriptional co-activator PCAF regulates cdk2 activity
Mateo, F., Vidal-Laliena, M., Canela, N., Zecchin, A., Martínez-Balbás, M., Agell, N., Giacca, M., Pujol, M. J., & Bachs, O. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp777 · Cited by 55
The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism
Santos, C. R., Vega, F. M. D. L., Blanco, S., Barcia, R., & Lazo, P. A. (2004) · Virology · doi:10.1016/j.virol.2004.08.013 · Cited by 57
Azalysine Analogues as Probes for Protein Lysine Deacetylation and Demethylation
Dancy, B. C. R., Ming, S. A., Papazyan, R., Jelinek, C. A., Majumdar, A., Sun, Y., Dancy, B. M., Drury, W. J., Cotter, R. J., Taverna, S. D., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209574z · Cited by 51
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira, N., & Yoshida, K. (2012) · PubMed · doi:10.14670/hh-27.437 · Cited by 61
Qian, C., Jin, J., Chen, J., Li, J., Yu, X., Mo, H., & Chen, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7773 · Cited by 53
RetractedDerepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53
Shao, J., Lu, J., Zhu, W., Yu, H. T., Jing, X., Wang, Y., Wang, X., & Wang, X. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0293-x · Cited by 51
Tasdemiroglu, Y., Gourdie, R. G., & He, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175192 · Cited by 50
Zou, B., Chim, C. S., Pang, R. W. C., Zeng, H., Dai, Y., Zhang, R., Lam, C. S. C., Tan, V. P. Y., Hung, I. F., Lan, H. Y., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20807 · Cited by 50
Carabetta, V. J., Greco, T. M., Cristea, I. M., & Dubnau, D. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815511116 · Cited by 49
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
Lazo, P. A. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.005 · Cited by 47
Wu, Y., Wang, X., Xu, F., Zhang, L., Wang, T., Fu, X., Jin, T., Zhang, W., & Ye, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa232 · Cited by 47
Target Gene Specificity of USF-1 Is Directed via p38-mediated Phosphorylation-dependent Acetylation
Corre, S., Primot, A., Baron, Y., Seyec, J. L., Goding, C. R., & Galibert, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808605200 · Cited by 49
Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development
Ghosh, T. K., Aparicio-Sánchez, J. J., Buxton, S., Ketley, A., Mohamed, T., Rutland, C. S., Loughna, S., & Brook, J. D. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.013 · Cited by 48
Tax1BP1 Interacts with Papillomavirus E2 and Regulates E2-Dependent Transcription and Stability
Wang, X., Naidu, S. R., Sverdrup, F. M., & Androphy, E. J. (2008) · Journal of Virology · doi:10.1128/jvi.01791-08 · Cited by 47
Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity
Zhang, H., Xiao, Y., Zhu, Z., Li, B., & Greene, M. I. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.101 · Cited by 46
Choudhary, V., Olala, L. O., Kagha, K. C., Pan, Z.-Q., Chen, X., Yang, R., Cline, A. E., Helwa, I., Marshall, L. E., Kaddour‐Djebbar, I., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.031 · Cited by 47
The regulation of radiosensitivity by p53 and its acetylation
Zhang, J., Shen, L., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.015 · Cited by 48
GSK3β N-terminus binding to p53 promotes its acetylation
Eom, T.-Y., & Jope, R. S. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-14 · Cited by 50
Reversible Acetylation Of Non Histone Proteins: Role in cellular function and disease
Batta, K., Das, C., Gadad, S. S., Shandilya, J., & Kundu, T. K. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_9 · Cited by 48
Carabetta, V. J., Greco, T. M., Tanner, A. W., Cristea, I. M., & Dubnau, D. A. (2016) · mSystems · doi:10.1128/msystems.00005-16 · Cited by 48
A possible overestimation of the effect of acetylation on lysine residues in KQ mutant analysis
Fujimoto, H., Higuchi, M., Koike, M., Ode, H., Pinák, M., Bunta, J. K., Nemoto, T., Sakudoh, T., Honda, N., Maekawa, H., et al. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21956 · Cited by 50
Wright, D. G., Marchal, C., Hoang, K., Ankney, J. A., Nguyen, S. T., Rushing, A. W., Polakowski, N., Miotto, B., & Lemasson, I. (2016) · Oncotarget · doi:10.18632/oncotarget.6424 · Cited by 44
Luo, J., Zhou, X., Ge, X., Liu, P., Cao, J., Lu, X., Ling, Y., & Zhang, S. (2013) · Cancer Science · doi:10.1111/cas.12248 · Cited by 46
Self-citationp53 and Ceramide as Collaborators in the Stress Response
Hage‐Sleiman, R., Esmerian, M. O., Kobeissy, H., & Dbaibo, G. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034982 · Cited by 44
Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke
Almeida, Á., Sánchez‐Morán, I., & Rodríguez, C. (2021) · IUBMB Life · doi:10.1002/iub.2453 · Cited by 45
Archaeal proteasomes and other regulatory proteases
Maupin-furlow, J. A., Gil, M. A., Humbard, M. A., Kirkland, P. A., Li, W., Reuter, C. J., & Wright, A. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.10.005 · Cited by 44
Acetylation Stimulates the Epithelial Sodium Channel by Reducing Its Ubiquitination and Degradation
Butler, P. L., Staruschenko, A., & Snyder, P. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.635540 · Cited by 43
Park, J.-M., Kim, T. H., JO, S., Kim, M.-Y., & Ahn, Y. (2015) · Scientific Reports · doi:10.1038/srep17395 · Cited by 44
STAT1 Signaling Is Not Regulated by a Phosphorylation-Acetylation Switch
Antunes, F., Marg, A., & Vinkemeier, U. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05300-11 · Cited by 39
SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation
Zhao, G., Wang, H., Xu, C., Wang, P., Chen, J., Wang, P., Sun, Z., Su, Y., Wang, Z., Han, L., et al. (2016) · Aging · doi:10.18632/aging.101038 · Cited by 42
Melatonin regulates the aging mouse hippocampal homeostasis via the sirtuin1-FOXO1 pathway
Jenwitheesuk, A., Boontem, P., Wongchitrat, P., Tocharus, J., Mukda, S., & Govitrapong, P. (2017) · EXCLI journal · doi:10.17179/excli2016-852 · Cited by 45
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 42
To breathe or not to breathe: Understanding how oxygen sensing contributes to age-related phenotypes
van Vliet, T., Casciaro, F., & Demaria, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101267 · Cited by 44
P2X 7 -mediated chemoprevention of epithelial cancers
Gorodeski, G. I. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903277249 · Cited by 40
Autoimmune regulator is acetylated by transcription coactivator CBP/p300
Saare, M., Rebane, A., Rajashekar, B., Vilo, J., & Peterson, P. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.013 · Cited by 42
Stochastic transcription in the p53‐mediated response to DNA damage is modulated by burst frequency
Friedrich, D., Friedel, L., Finzel, A., Herrmann, A., Preibisch, S., & Loewer, A. (2019) · Molecular Systems Biology · doi:10.15252/msb.20199068 · Cited by 41
Valli, C., Paroni, G., Francesco, A. M. D., Riccardi, R., Tavecchio, M., Erba, E., Boldetti, A., Gianni’, M., Fratelli, M., Pisano, C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0419 · Cited by 42
Baresova, P., Musilová, J., Pitha, P. M., & Lubyová, B. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01011-13 · Cited by 42
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Dying to Survive—The p53 Paradox
Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 41
Fraiberg, M., Afanzar, O., Cassidy, C. K., Gabashvili, A., Schulten, K. J., Levin, Y., & Eisenbach, M. (2014) · Molecular Microbiology · doi:10.1111/mmi.12858 · Cited by 39
Ono, W., Hayashi, Y., Yokoyama, W., Kuroda, T., Kishimoto, H., Ito, I., Kimura, K., Akaogi, K., Waku, T., & Yanagisawa, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474049 · Cited by 45
Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes
Herbert, K. J., Holloway, A. F., Cook, A. L., Chin, P. S., & Snow, E. T. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.09.012 · Cited by 40
Ceseña, T. I., Cui, T. X., Subramanian, L., Fulton, C. T., Iñiguez-Lluhí, J. A., Kwok, R. P. S., & Schwartz, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.03.009 · Cited by 42
Liu, Z., Liu, Y., Wang, H., Ge, X., Jin, Q., Ding, G.-H., Hu, Y., Zhou, B. Z., Chen, Z., Ge, X., et al. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.08.009 · Cited by 38
He, X., Ni, Y., Wang, Y., Romigh, T., & Eng, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq434 · Cited by 44
White, D. E., Talbott, K. E., Arva, N. C., & Bargonetti, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1381 · Cited by 36
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
Wahl, G. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401911 · Cited by 47
Lysine Methylation Promotes VEGFR-2 Activation and Angiogenesis
Hartsough, E. J., Meyer, R., Chitalia, V. C., Jiang, Y., Márquez, V. E., Zhdanova, I. V., Weinberg, J., Costello, C. E., & Rahimi, N. (2013) · Science Signaling · doi:10.1126/scisignal.2004289 · Cited by 36
Nuclear phosphoinositide regulation of chromatin
Hamann, B. L., & Blind, R. D. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25886 · Cited by 38
Resveratrol is an effective inducer of CArG-driven TNF-α gene therapy
Bickenbach, K. A., Veerapong, J., Shao, M. Y., Mauceri, H. J., Posner, M. C., Kron, S. J., & Weichselbaum, R. R. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701103 · Cited by 36
MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
Akaogi, K., Ono, W., Hayashi, Y., Kishimoto, H., & Yanagisawa, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-65 · Cited by 40
Haaland, I., Opsahl, J. A., Berven, F. S., Reikvam, H., Fredly, H., Haugse, R., Thiede, B., McCormack, E., Laín, S., Bruserud, Ø., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-116 · Cited by 38
Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis
Gopu, V., Fan, L., Shetty, R. R., Nagaraja, M. R., & Shetty, S. (2020) · JCI Insight · doi:10.1172/jci.insight.137969 · Cited by 35
Liu, D., Liu, C., Li, J., Azadzoi, K., Yang, Y., Fei, Z., Dou, K., Kowall, N. W., Choi, H.-P., Vieira, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080779 · Cited by 34
Regulation of P2X7 gene transcription
Zhou, L., Luo, L., Qi, X., Li, X., & Gorodeski, G. I. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9167-x · Cited by 35
The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy
Sui, G. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.20 · Cited by 34
Therapeutic Strategies to Activate p53
Aguilar, A., & Wang, S. (2022) · Pharmaceuticals · doi:10.3390/ph16010024 · Cited by 34
He, G., Wang, Q., Zhou, Y., Wu, X., Wang, L., Duru, N., Kong, X., Zhang, P., Wan, B., Sui, L., et al. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31821d2525 · Cited by 31
Assessing acetylation of NF-κB
Chen, L., & Greene, W. C. (2005) · Methods · doi:10.1016/j.ymeth.2005.03.011 · Cited by 36
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31
Novel p53 therapies for head and neck cancer
Castellanos, M. R., & Pan, Q. (2016) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2016.05.005 · Cited by 34
p53 Response to Arsenic Exposure in Epithelial Cells: Protein Kinase B/Akt Involvement
Sandoval, M., Morales, M., Tapia, R., Alarcón‐Romero, L. D. C., Sordo, M., Ostrosky‐Wegman, P., Ortega, A., & López‐Bayghen, E. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm153 · Cited by 33
Protein lysine acetylation and its role in different human pathologies: a proteomic approach
Morales-Tarré, O., Alonso-Bastida, R., Arcos-Encarnación, B., Pérez‐Martínez, L., & Encarnación‐Guevara, S. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.2007766 · Cited by 32
Jung, J. H., Lee, H., Zeng, S. X., & Lu, H. (2020) · Cells · doi:10.3390/cells9092107 · Cited by 29
Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth
Sharma, B. K., Mureb, D., Murab, S., Rosenfeldt, L. A., Francisco, B. J., Cantrell, R., Karns, R. A., Romick‐Rosendale, L. E., Watanabe‐Chailland, M., Mast, E. M., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15440 · Cited by 41
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2016) · BioEssays · doi:10.1002/bies.201670906 · Cited by 32
Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth
Zhang, Y.-W., Zhang, Q., Zeng, S. X., Zhang, Y., Mayo, L. D., & Lu, H. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20844 · Cited by 29
Song, L., Gao, M., Dong, W., Hu, M., Li, J., Shi, X., Hao, Y., Li, Y., & Huang, C. (2010) · Oncogene · doi:10.1038/onc.2010.506 · Cited by 31
Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis
Xu, W., Jin, Q., Li, X., Li, D., Fu, X., Chen, N., Lv, Q., Shi, Y., He, S., Dong, L., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06505-z · Cited by 28
Deregulation of cyclin E meets dysfunction in p53: Closing the escape hatch on breast cancer
Barton, M. C., Akli, S., & Keyomarsi, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20818 · Cited by 30
p53 Regulates Cellular Resistance to Complement Lysis through Enhanced Expression of CD59
Donev, R., Cole, D., Sivasankar, B., Hughes, T. R., & Morgan, B. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3191 · Cited by 28
RetractedThe role of acetylation sites in the regulation of p53 activity
Wang, Y., Chen, Y., Chen, Q., Zhang, X., Wang, H., Wang, Z., Wang, J., & Tian, C. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05141-7 · Cited by 30
Roychowdhury, S., Baiocchi, R. A., Vourganti, S., Bhatt, D., Blaser, B. W., Freud, A. G., Chou, J., Chen, C., Xiao, J. J., Parthun, M. R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh271 · Cited by 28
KeePin’ the p53 Family in Good Shape
Mantovani, F., Gostissa, M., Collavin, L., & Sal, G. D. (2004) · Cell Cycle · doi:10.4161/cc.3.7.999 · Cited by 32
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
Huang, Y., Wang, L., Zhou, Y., Bai, J., Li, N., Su, Z., & Cheng, X. (2025) · Cells · doi:10.3390/cells14080583 · Cited by 27
Liu, J., Tao, X., Zhu, Y., Li, C. V., Ruan, K., Diaz-Perez, Z., Rai, P., Wang, H., & Zhai, R. G. (2021) · eLife · doi:10.7554/elife.70046 · Cited by 30
cAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases
Kloster, M. M., Naderi, E. H., Haaland, I., Gjertsen, B. T., Blomhoff, H. K., & Naderi, S. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1853 · Cited by 32
Thangapandian, S., John, S., & Lee, K. W. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.10507409 · Cited by 28
Law, M. J., Mallory, M. J., Dunbrack, R. L., & Strich, R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00256-13 · Cited by 27
Effects of ethanol on hepatic cellular replication and cell cycle progression
Clemens, D. L. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i37.4955 · Cited by 27
The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth
Xu, F., Sun, H., Fang, R., Zhang, L., Shi, H., Wang, X., Fu, X., Li, X.-M., Shi, X.-H., Wu, Y., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00631-6 · Cited by 26
Blue Light Damage and p53: Unravelling the Role of p53 in Oxidative-Stress-Induced Retinal Apoptosis
Fietz, A., Corsi, F., Hurst, J., & Schnichels, S. (2023) · Antioxidants · doi:10.3390/antiox12122072 · Cited by 27
Meijer, D. H., Sun, Y., Liu, T., Kane, M., Alberta, J. A., Adelmant, G., Kupp, R., Marto, J. A., Rowitch, D. H., Nakatani, Y., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0309-14.2014 · Cited by 27
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 28
Metadata
- Authors
- Li, M., Luo, J., Brooks, C. L., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50607-50611
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082541302
- Cited by
- 503
- References
- 34
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6528 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (5-T32-CAO9503-17, T32CA009503)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 acetylation, MDM2, ubiquitination, p53 stabilization, post-translational modification, DNA damage response, tumor suppressor regulation, site competition
- MeSH terms
- Acetylation, Animals, Burkitt Lymphoma, Cloning, Molecular, DNA Damage, HeLa Cells, Humans, Kinetics, Neoplasm Proteins, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Recombinant Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Ubiquitin, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.